The value of plasma Interleukin-6 and Interleukin-8 levels in the monitoring of patients with breast cancer;Wartość oznaczania interleukiny 6 i 8 w osoczu w monitorowaniu leczenia chorych na raka piersi

Polski Merkuriusz Lekarski

Volumn 18, Issue 106, 2005, Pages 424-426

  Zakrzewska, Irena ^a   Omyła, Jacek ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Oddział Chirurgii Onkologicznej Białostockiego Osrodka Onkologicznego ^*

Author keywords

Breast cancer; Chemotherapy; IL 6; IL 8; Plasma

Indexed keywords

ANTIINFECTIVE AGENT; INTERLEUKIN 6; INTERLEUKIN 8;

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; PATIENT MONITORING; REMISSION;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 18444408362     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Basolo F., Flore L., Fontanini G. i wsp.: Expression of and response to interleukin 6 (IL 6) in human mammary tumors. Cancer Res., 1996, 56, 3118-3122.
2. Chopra V. i wsp.: Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest., 1998, 16 (3), 152-159.
3. De Panfilis G.: Immune molecular microenvironment and skin tumors. Ann. Ital. Dermatol. Clin. Sper., 2000, 54, 93.
4. Gado K. i wsp.: Role of interleukin 6 in the pathogenesis of multiple myeloma. Cell Biol. Int., 2000, 24, 195-209.
5. Green A.R. i wsp.: Expression of cytokine messenger RNA in normal and neoplastic human breast tissue identification of interleukin 8 as a potential regulatory factor in breast tumors. Int. J. Cancer., 1997, 72, 937-941.
6. Herbert C.A., Baker J.B.: Interleukin 8: a review. Cancer Invest., 1993, 11, 743-750.
7. Ivarsson K. i wsp.: The chemotactin cytokine interleukin 8 a cyst fluid marker for malignant epithelial ovarian cancer. Gynecol Oncol., 1998, 71, 420-423.
8. Karczewska A., Mackiewicz A.: Analiza ekspresji genów cytokin II-6 i ich receptorów w tkankach raka sutka. Klin. Perinatol. Gin., 2003, 39 (2), 21-27.
9. Kishimoto T.: The biology of interleukin 6. Blood, 1989, 74, 1-10.
10. Kurebayashi J., Otsuki T., Tang C.K.: Isolation and characterization of a new human breast cancer cell line KPL-4, expressing the Erb B family receptors and interleukin 6. Br. J. Cancer, 1999, 79, 707-717.
11. Musiani P., Modesti A., Giovarelli M. i wsp.: Cytokines tumor cell death and immunogenicity: a question of choice. Immunol. Tod., 1997, 18 (1), 32-36.
12. Strassman G., Fong M., Kenney J. i wsp.: Evidence for the involvement of Interleukin 6 in experimental cancer cachexia. J. Clin. Invest., 1992, 89, 1681-1684.
13. Yoshida S. i wsp.: Involvement of interleukin 8 vascular endothelial growth factor and basic fibroblast growth factor in tumor necrosis factor alpha dependent angiogenesis. Mol. Cell Biol., 1997, 17, 4015-4023.
14. Zakrzewska I., Kozłowski L., Wojtukiewicz M.: Przydatnoś ć oznaczania interleukiny 8 w diagnostyce łagodnych i złośliwych nowotworów sutka. Pol. Merk. Lek., 2002, 13 (76), 302-304.
15. Zakrzewska I., Kozłowski L., Wojtukiewicz M.: Ocena zmian stȩżeń interleukiny 6 i białka C-reaktywnego u chorych na nowotwory piersi. Pol. Merk. Lek., 2003, 15 (86), 115-117.